Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
Clinical trial NCT01804712 · COMPLETED
Trial details
- NCT number
- NCT01804712
- Sponsor
- Christopher Kane
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2020-06-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.